Universitäres Krebszentrum (UCCL)

Veröffentlichungen in 2015

  • Lordick F: Supportive Tumortherapien. In: Erckenbrecht JF, Jonas S (Hg.): Viszeralmedizin., Springer, Berlin Heidelberg (2015); 440-445, ISBN ISBN 978-3-642-14301-4
  • Bahra M, Lordick F, Lutz M, Glanemann M, Neuhaus P: Pankreaskarzinom In: Erckenbrecht JF, Jonas S (Hg.): Viszeralmedizin., Springer, Berlin Heidelberg (2015); 557-567, ISBN 978-3-642-14301-4
  • Ott K, Lordick F, Siewert JR: Oesophageal Cancer: Treatment Strategies In: (Hg.): Kuzdzal J. Textbook of Thoracic Surgery, Volume 2, Medycyna Praktyczna, Cracow (2015); 591-600, ISBN 978-83-7430-331-6
  • Fakhrian K, Ordu AD, Nieder C, Lordick F, Kup PG, Theisen J, Combs SE, Geinitz H: Outcomes of patients with squamous cell carcinoma of esophagus who did not receive surgical resection after neoadjuvant radiochemotherapy. In: Tumori 2015; 101(3): 263-267 [IF 1,269]
  • Schmidt T, Lordick F, Herrmann K, Ott K: Value of functional imaging by PET in esophageal cancer. In: J Natl Compr Canc Netw 2015; 13(2): 239-247 [IF 4,178]
  • Moehler M, Baltin CT, Ebert M, Fischbach W, Gockel I, Grenacher L, Holscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer HJ, Palmqvist A, Rocken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wi: International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. In: Gastric Cancer 2015; 18(3): 550-563 [IF 3,719]
  • Blank S, Lordick F, Bader F, Burian M, Dobritz M, Grenacher L, Becker K, Weichert W, Langer R, Sisic L, Stange A, Jager D, Buchler M, Bruckner T, Siewert J, Ott K: Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation. In: Gastric Cancer 2015; 18(2): 314-325 [IF 3,719]
  • Schmidt T, Alldinger I, Blank S, Klose J, Springfeld C, Dreikhausen L, Weichert W, Grenacher L, Bruckner T, Lordick F, Ulrich A, Buchler MW, Ott K: Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection. In: Eur J Surg Oncol 2015; 41(10): 1340-1347 [IF 3,009]
  • Weihrauch MR, Richly H, von Bergwelt-Baildon MS, Schmidt M, Hacker UT, Alexander Shimabukuro A, Holtick U, Nokay B, Schroff M, Wittig B, Scheulen ME : Phase I clinical study of the TLT9-agonist MGN1703 in patients with metastatic solid tumors. In: Eur J Cancer 2015; 51(2): 146-156 [IF 5,417]
  • Boehm A, Lindner F, Wichmann G, Bauer U, Wittekind C, Knoedler M, Lordick F, Dietzsch S, Scholz M, Kortmann R, Dietz A: Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma. In: Eur Arch Otorhinolaryngol 2015; 272(8): 2017-2025 [IF 1,545]
  • Peeters M, Oliner KS, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, Andre T, Chan E, Lordick F, Punt CJ, Strickland AH, Wilson G, Ciuleanu TE, Roman L, Van Cutsem E, He P, Yu H, Koukakis R, T: Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer. In: Clin Cancer Res 2015; 21(24): 5469-5479 [IF 8,722]
  • Scheffold K, Philipp R, Engelmann D, Schulz-Kindermann F, Rosenberger C, Oechsle K, Harter M, Wegscheider K, Lordick F, Lo C, Hales S, Rodin G, Mehnert A: Efficacy of a brief manualized intervention Managing Cancer and Living Meaningfully (CALM) adapted to German cancer care settings: study protocol for a randomized controlled trial. In: BMC Cancer 2015; 15: 592 [IF 3,362]
  • Leong T, Smithers BM, Michael M, Gebski V, Boussioutas A, Miller D, Simes J, Zalcberg J, Haustermans K, Lordick F, Schuhmacher C, Swallow C, Darling G, Wong R: TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG). In: BMC Cancer 2015; 15: 532 [IF 3,362]
  • Springfeld C, Wiecha C, Kunzmann R, Heger U, Weichert W, Langer R, Stange A, Blank S, Sisic L, Schmidt T, Lordick F, Jager D, Grenacher L, Bruckner T, Buchler MW, Ott K: Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma. In: Ann Surg Oncol 2015; 22 (Suppl 3): 905-914 [IF 3,93]
  • Behrens A, Ell C, Lordick F: Perioperative and Palliative Chemotherapy for Esophageal Cancer. In: Viszeralmedizin 2015; 31(5): 341-346 [IF 0]
  • Lordick F: Gastrointestinal cancer. Over the RAINBOW--renaissance in antiangiogenesis. In: Nat Rev Clin Oncol 2015; 12(1): 7-8 [IF 14,18]
  • Lordick F: [In Process Citation]. In: Oncol Res Treat 2015; 38(5): 260-263 [IF 0]
  • Lorenzen S, Riera Knorrenschild J, Haag GM, Pohl M, Thuss-Patience P, Bassermann F, Helbig U, Weissinger F, Schnoy E, Becker K, Stocker G, Ruschoff J, Eisenmenger A, Karapanagiotou-Schenkel I, Lordick F: Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. In: Eur J Cancer 2015; 51(5): 569-576 [IF 5,417]
  • Lordick F, Gockel I, Wittekind C : Magenkarzinom: Neue molekulare Konzepte. In: Dtsch Arztebl 2015; 112(20): 10.3238 [IF 0]
  • Hacker U, Lordick F: [Current standards in the treatment of gastric cancer]. In: Dtsch Med Wochenschr 2015; 140(16): 1202-1205 [IF 0,542]
  • Gockel I, Hoffmeister A, Lordick F: [Neoadjuvant therapy for tumors of the upper gastrointestinal tract : Complication management]. In: Chirurg 2015; 86(11): 1014-1022 [IF 0,574]
  • Buning H, Huber A, Zhang L, Meumann N, Hacker U: Engineering the AAV capsid to optimize vector-host-interactions. In: Curr Opin Pharmacol 2015; 24: 94-104 [IF 4,595]
  • Coutelle O, Schiffmann LM, Liwschitz M, Brunold M, Goede V, Hallek M, Kashkar H, Hacker UT: Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalization without inducing empty basement membrane sleeves in xenograft tumors. In: Br J Cancer 2015; 112(3): 495-503 [IF 4,836]

letzte Änderung: 26.07.2012


Universitäres Krebszentrum (UCCL)
Lordick, Florian (Prof. Dr.)
Liebigstraße 20 a
04103 Leipzig
Telefon: ++49 341 97-12560
Fax: ++49 341 97-17709


Dezernat für Forschungs- und Transferservice
Ritterstraße 26
(3. Etage)
04109 Leipzig
Telefon: +49 341 97-35000
Telefax: +49 341 97-35009


Wählen Sie bitte das Berichtsjahr.